Fetal and maternal peroxisome proliferator-activated receptor γ2 Pro12Ala does not influence birth weight

Obesity

Volumn 14, Issue 11, 2006, Pages 1880-1885

  Pfab, Thiemo ^a,b   Poralla, Christine ^a   Richter, Claus Michael ^a,b   Godes, Michael ^a   Slowinski, Torsten ^b   Priem, Friedrich ^b   Halle, Horst ^b   Hocher, Berthold ^a,b  

^a DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Diabetes; Fetal programming; Genetic association study; Genetic polymorphism; Intrauterine growth

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ARTICLE; BIRTH WEIGHT; BODY HEIGHT; BODY WEIGHT; ENERGY METABOLISM; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY;

BIRTH WEIGHT; BODY HEIGHT; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFANT, NEWBORN; INSULIN RESISTANCE; MALE; POLYMORPHISM, GENETIC; PPAR GAMMA; PREGNANCY;

EID: 33846278347     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2006.218     Document Type: Article

References (16)

1. Deeb SS, Fajas L, Nemoto M, et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998;20:284-7.
2. Altshuler D, Hirschhorn JN, Klannemark M, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000;26:76-80.
3. Lindi V, Sivenius K, Niskanen L, Laakso M, Uusitupa MI. Effect of the Pro12Ala polymorphism of the PPAR-gamma2 gene on long-term weight change in Finnish non-diabetic subjects. Diabetologia. 2001;44:925-6.
4. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet. 1989;2:577-80.
5. Rich-Edwards JW, Colditz GA, Stampfer MJ, et al. Birth-weight and the risk for type 2 diabetes mellitus in adult women. Ann Intern Med. 1999;130:278-84.
6. Eriksson JG, Lindi V, Uusitupa M, et al. The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth. Diabetes. 2002;51:2321-4.
7. Yliharsila H, Eriksson JG, Forsen T, et al. Interactions between peroxisome proliferator-activated receptor-gamma 2 gene polymorphisms and size at birth on blood pressure and the use of antihypertensive medication. J Hypertens. 2004;22:1283-7.
8. Pihlajamaki J, Vanhala M, Vanhala P, Laakso M. The Pro 12Ala polymorphism of the PPAR gamma 2 gene regulates weight from birth to adulthood. Obes Res. 2004;12:187-90.
9. Hocher B, Slowinski T, Stolze T, Pleschka A, Neumayer HH, Halle H. Association of maternal G protein beta3 subunit 825T allele with low birthweight. Lancet. 2000;355:1241-2.
10. Shaat N, Ekelund M, Lernmark A, et al. Genotypic and phenotypic differences between Arabian and Scandinavian women with gestational diabetes mellitus. Diabetologia. 2004;47:878-84.
11. Jaquet D, Tregouet DA, Godefroy T, et al. Combined effects of genetic and environmental factors on insulin resistance associated with reduced fetal growth. Diabetes. 2002;51:3473-8.
12. Colhoun HM, McKeigue PM, Davey SG. Problems of reporting genetic associations with complex outcomes. Lancet. 2003;361:865-72.
13. Yajnik CS, Fall CH, Vaidya U, et al. Fetal growth and glucose and insulin metabolism in four-year-old Indian children. Diabet Med. 1995;12:330-6.
14. Hocher B, Slowinski T, Bauer C, Halle H. The advanced fetal programming hypothesis. Nephrol Dial Transplant. 2001;16:1298-9.
15. Li Q, Cheon YP, Kaiman A, Shanker S, Bagchi IC, Bagchi MK. A novel pathway involving progesterone receptor, 12/15-lipoxygenase-derived eicosanoids, and peroxisome proliferator-activated receptor gamma regulates implantation in mice. J Biol Chem. 2004;279:11570-81.
16. Hocher B, Slowinski T, Hauser I, et al. Association of factor V Leiden mutation with delayed graft function, acute rejection episodes and long-term graft dysfunction in kidney transplant recipients. Thromb Haemost. 2002;87:194-8.